SynthesisJCO precision oncology2022

Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.

Matthew Dankner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.